Morag J Young (Morag Young)

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 19

Top Venues

Journal of human hypertension

Intensive care medicine

Journal of molecular endocrinology

Stroke

Baker Heart and Diabetes Institute

Monash University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Baker Heart and Diabetes Institute May 01 2020

Australia

Associate Professor, Alice Baker and Eleanor Shaw Gender Equity Fellow :: Cardiovascular Endocrinology

Education History

Monash University

Australia

PHD :: Medicine and Surgery

Monash University

Australia

BSC :: Biomedical Science

Publications

Sonali S Shah, Jinghong Zhang, Stella May Gwini, Morag J Young, Peter J Fuller, Jun Yang
Efficacy and safety of mineralocorticoid receptor antagonists for the treatment of low-renin hypertension: a systematic review and meta-analysis. Journal of human hypertension (2024)
Sonali S Shah, Stella May Gwini, Michael Stowasser, Christopher M Reid, Morag J Young, Peter J Fuller, Jun Yang
A Randomized trial assessing Efficacy and safety of Mineralocorticoid receptor Antagonist therapy compared to Standard antihypertensive Therapy in hypErtension with low Renin (REMASTER): rationale and study design. Journal of human hypertension (2024)
Sonali S Shah, Jinghong Zhang, Stella May Gwini, Morag J Young, Peter J Fuller, Jun Yang
Efficacy and safety of mineralocorticoid receptor antagonists for the treatment of low-renin hypertension: a systematic review and meta-analysis. Journal of human hypertension 38 (5) (2024)
Sonali S Shah, Peter J Fuller, Morag J Young, Jun Yang
Update on Low-Renin Hypertension: Current Understanding and Future Direction. Hypertension (Dallas, Tex. : 1979) (2024)
Sonali S Shah, Jinghong Zhang, Stella May Gwini, Morag J Young, Peter J Fuller, Jun Yang
Efficacy and safety of mineralocorticoid receptor antagonists for the treatment of low-renin hypertension: a systematic review and meta-analysis. Journal of human hypertension 38 (5) (2024)
Sonali S Shah, Jinghong Zhang, Stella May Gwini, Morag J Young, Peter J Fuller, Jun Yang
Efficacy and safety of mineralocorticoid receptor antagonists for the treatment of low-renin hypertension: a systematic review and meta-analysis. Journal of human hypertension (2024)
Sonali S Shah, Jinghong Zhang, Stella May Gwini, Morag J Young, Peter J Fuller, Jun Yang
Efficacy and safety of mineralocorticoid receptor antagonists for the treatment of low-renin hypertension: a systematic review and meta-analysis. Journal of human hypertension 38 (5) (2024)
Sonali S Shah, Jinghong Zhang, Stella May Gwini, Morag J Young, Peter J Fuller, Jun Yang
Efficacy and safety of mineralocorticoid receptor antagonists for the treatment of low-renin hypertension: a systematic review and meta-analysis. Journal of human hypertension 38 (5) (2024)
Sonali S Shah, Jinghong Zhang, Stella May Gwini, Morag J Young, Peter J Fuller, Jun Yang
Efficacy and safety of mineralocorticoid receptor antagonists for the treatment of low-renin hypertension: a systematic review and meta-analysis. Journal of human hypertension 38 (5) (2024)
James Walsham, Naomi E Hammond, Antje Blumenthal, Jeremy Cohen, John A Myburgh, Simon R Finfer, David M Evans, Sandra L Peake, Peter S Kruger, James McCullough, Loki Johnk, Dhaval Ghelani, Laurent Billot, Sana Shan, Jason Meyer, Dorrilyn Rajbhandari, Carolyn Koch, Rinaldo Bellomo, Louise M Burrell, Morag J Young, Michael S Roberts, Lorraine Mackenzie, Gregory Medley, Joshua Dalton, Balasubramanian Venkatesh
Fludrocortisone dose-response relationship in septic shock: a randomised phase II trial. Intensive care medicine (2024)
Monica Kanki, Artika P Nath, Ruidong Xiang, Stephanie Yiallourou, Peter J Fuller, Timothy J Cole, Rodrigo Cánovas, Morag J Young
Poor sleep and shift work associate with increased blood pressure and inflammation in UK Biobank participants. Nature communications 14 (1) (2023)
Morag J Young, Colin D Clyne
Mineralocorticoid receptor actions in cardiovascular development and disease. Essays in biochemistry 65 (6) (2022)
Nikshay Karthigan, Siobhan Lockwood, Anthony White, Jun Yang, Morag J Young
Mineralocorticoid receptor antagonists, heart failure and predictive biomarkers. The Journal of endocrinology 253 (3) (2022)
Colin D Clyne, Kevin P Kusnadi, Alexander Cowcher, James Morgan, Jun Yang, Peter J Fuller, Morag J Young
Regulation of mineralocorticoid receptor activation by circadian protein TIMELESS. Journal of molecular endocrinology 70 (1) (2022)
Morag J Young, Monica Kanki, Nikshay Karthigan, Penny Konstandopoulos
The Role of the Mineralocorticoid Receptor and Mineralocorticoid Receptor-Directed Therapies in Heart Failure. Endocrinology 162 (11) (2022)
Josephine McCarthy, Jun Yang, Ben Clissold, Morag J Young, Peter J Fuller, Thanh Phan
Hypertension Management in Stroke Prevention: Time to Consider Primary Aldosteronism. Stroke 52 (10) (2021)
Pravik Solanki, Stella May Gwini, James C G Doery, Kay Weng Choy, Jimmy Shen, Morag J Young, Peter J Fuller, Jun Yang
Age- and sex-specific reference ranges are needed for the aldosterone/renin ratio. Clinical endocrinology 93 (3) (2020)
Morag J Young, Monica Kanki, Peter J Fuller, Jun Yang
Identifying new cellular mechanisms of mineralocorticoid receptor activation in the heart. Journal of human hypertension 35 (2) (2020)
Peter J Fuller, Yi-Zhou Yao, Jun Yang, Morag J Young
Structural determinants of activation of the mineralocorticoid receptor: an evolutionary perspective. Journal of human hypertension 35 (2) (2020)

Morag J Young.css-eqlu8i{font-size:small;padding-left:4px;} (Morag Young)

Publication Activity (10 Years)

Top Topics

Top Venues

Morag J Young (Morag Young)